Short Interest in Biofrontera Inc. Declines By 22.7
| BFRI Stock | USD 1.13 0.01 0.89% |
Under 53% of Biofrontera's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Biofrontera suggests that some traders are interested. Biofrontera's investing sentiment shows overall attitude of investors towards Biofrontera.
Biofrontera |
Biofrontera Inc. was the target of a large drop in short interest in December. As of December 15th, there was short interest totalling 530,600 shares, a drop of 22.7 percent from the November 30th total of 686,600 shares. Currently, 8.5 percent of the companys stock are sold short. Based on an average
Read at thelincolnianonline.com
 |
Biofrontera Fundamental Analysis
We analyze Biofrontera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofrontera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofrontera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Biofrontera is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Biofrontera Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biofrontera stock to make a market-neutral strategy. Peer analysis of Biofrontera could also be used in its relative valuation, which is a method of valuing Biofrontera by comparing valuation metrics with similar companies.
Peers
Biofrontera Related Equities
| CPHI | China Pharma | 26.09 | ||||
| SBFMW | Sunshine Biopharma | 15.79 | ||||
| PRFX | Painreform | 4.52 | ||||
| PTPI | Petros Pharmaceuticals | 2.50 | ||||
| SXTC | China SXT | 1.92 | ||||
| CPIX | Cumberland Pharmaceuticals | 0.43 | ||||
| EVOK | Evoke Pharma | 0.86 | ||||
| AKAN | Akanda Corp | 1.80 | ||||
| IXHL | Incannex Healthcare | 2.05 | ||||
| SHPH | Shuttle Pharmaceuticals | 4.30 | ||||
| RGC | Regencell Bioscience | 5.22 | ||||
| PROC | Procaps Group | 12.44 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |